baber/WOPTO huggingface dataset:
Patent AU-2020268164-A1 (AU)
Title: Seawater treatment to obtain high salinity water with low hardness for enhanced oil recovery
Inventor: ANTONOPOULOS NICK
IPC: B01D61/12
Filed: 2020-04-13
Abstract: A high salinity feed water such as seawater is treated to produce a reverse osmosis (RO) concentrate and an RO permeate. Optionally, some or all of the RO concentrate may be filtered to produce a nanofiltration (NF) permeate. Optionally, some feed water can also be filtered to produce NF permeate without first being concentrated by RO treatment. The NF permeate, or a blend of the RO permeate and NF permeate, may be used to produce a product water for injection into an oil-bearing reservoir to enhance oil recovery. Optionally, the product water may have salinity greater than the feedwater, or at least 30 g/L. The product water may have hardness of less than 20 mg/L.
Patent AU-2020270353-A1 (AU)
Title: Strapping tool
Inventor: KELLER ANDREAS
IPC: B65B13/34
Filed: 2020-04-22
Abstract: Various embodiments of the present disclosure provide a strapping tool configured to tension metal strap around a load and, after tensioning, attach overlapping portions of the strap to one another by cutting notches into a seal element positioned around the overlapping portions of the strap and into the overlapping portions of the strap themselves.
Patent AU-2020273383-A1 (AU)
Title: A traditional Chinese medicine composition for COVID-19 and/or influenza and preparation method thereof
Inventor: Fang Wen Quan
IPC: A61K36/481
Filed: 2020-11-20
Abstract: te present invention provides a traditional Chinese medicine (TCM) composition for COVID19 and/or influenza and 
preparation method thereof, and is in the technical field of traditional Chinese medicine. The traditional Chinese 
medicine composition for COVID-19 and/or influenza provided by the present invention includes the following 
mponents by weight: 5~30 portions of raw Huang Qi, 5~30 portions of Ge Gen, 5~30 portions of Chai Hu, 5~30 
rtions of Jin Yin Hua, 5~30 portions of Lian Qiao, 5~30 portions of Huo Xiang, 2~20 portions of wine-processed 
i Huang, 5~30 portions of Jie Geng, 3~30 portions of raw Yin Yang Huo, 5~30 portions of bran-flied Cang Shu, 
,30 portions of Lai Fu Zi, 3~20 portions of Chen Pi, 5~30 portions of Bai Shao, 5~30 portions of Fu Ling, 3~20 
rtions of Bo He and 2~20 portions of Gan Cao. The above traditional Chinese medicine composition has the 
actions of strengthening the spleen, regulating the vital energy, clearing the damp and heat, lightly ventilate the 
rface, and strengthening the body, and can be used for the prevention and treatment of COVID-19 and influenza.
1,99% 0.40% 
0 
Figure 1: Dosages Administered 
2 Doses, 3 Doses, 5 Doses,7 Doses 
Figure 2: Sex Ratio 
Male, Female 
0.40% 
Figure 3 Pre-medication Condition 
Normal, Abnormal 
1/1
Patent AU-2020281094-A1 (AU)
Title: Effecting initiation and authorization of transactions between mobile devices
Inventor: GLENDENNING CRAIG
IPC: G06Q20/32
Filed: 2020-12-03
Abstract: Some embodiments relate to a method comprising: a first mobile device detecting a 
radio signal and an associated authorisation request packet from a second mobile 
5 device over a Bluetooth Low Energy interface, the authorisation request packet 
including a first data attribute comprising a unique identifier of the second mobile 
device and a second data attribute comprising a first predetermined RSSI data value; 
determining a received signal strength indicator (RSSIm) of the detected radio signal; 
storing the RSSIm together with an associated time stamp in an historic data structure; 
10 calculating an average RSSI value, RSSIavg, by performing an averaging analysis on 
stored RSSIm values in the historical data structure that are associated with the first data 
attribute; and if RSSIavg meets or exceeds the first predetermined RSSI data value, 
preparing transaction data received from the second mobile device for display on an 
interface of the first mobile device.
2/3 
I I 
| O IN OI 
0- I N e 
- - ~I ~I cO 
C -------.- -- I -) 
U ~IH 
. - - . -. -- -o 
.... .... .  
C)I 
It -C 01 
0Z 
201z
Patent AU-2020286323-A1 (AU)
Title: Co-stimulatory domains for use in genetically-modified cells
Inventor: JANTZ DEREK
IPC: C07K14/705
Filed: 2020-12-11
Abstract: The present disclosure provides novel co-stimulatory domains useful in genetically
modified cells to promote cell proliferation and/or promote cytokine secretion after antigen 
recognition. For example, disclosed herein are genetically-modified cells comprising a chimeric 
antigen receptor or an inducible regulatory construct incorporating the co-stimulatory domains 
disclosed herein. Also disclosed herein are plasmids and viral vectors comprising a nucleic acid 
sequence encoding the co-stimulatory domains, and methods of administering compositions 
comprising the novel co-stimulatory domains to subjects in order to reduce the symptoms, 
progression, or occurrence of disease, such as cancer.
Patent AU-2020314724-A1 (AU)
Title: Reconfigurable cases for portable hand-held devices and methods
Inventor: BURNS BRENDAN V
IPC: A45F3/00
Filed: 2020-07-15
Abstract: A case for a portable hand-held devices, such as binoculars. The case assembly includes a main case portion having an opening defined by a periphery and a cover. A reconfigurable member is attached to at least a portion of the cover and can be configured to correspond to an outer profile of the hand-held device being stored within the case.
Patent AU-2020321880-A1 (AU)
Title: Antioxidant and antiviral compositions and methods
Inventor: PETERSON TIMOTHY
IPC: A61K31/197
Filed: 2020-07-23
Abstract: Preparations of exosomes and/or Purified Exosome Product (PEP) include antioxidant proteins and antiviral proteins. Compositions that include exosomes and/or PEP can be used to treat subject having, or at risk of having, a condition or tissue damage caused, at least in part, by oxidative stress. Also, compositions that include exosomes and/or PEP can be used to treat subject having, or at risk of having, a viral infection.
Patent AU-2020347147-A1 (AU)
Title: Novel CRISPR DNA targeting enzymes and systems
Inventor: SCOTT DAVID A
IPC: A61K38/46
Filed: 2020-09-09
Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of nucleic acids. Each system includes one or more protein components and one or more nucleic acid components that together target nucleic acids.
Patent AU-2020359946-A1 (AU)
Title: Dentifrice compositions comprising bicarbonate salt and neutral amino acid
Inventor: STRAND ROSS
IPC: A61K8/21
Filed: 2020-09-30
Abstract: Dentifrice compositions comprising water, bicarbonate salt, and glycine or a salt thereof are effective in treating dental plaque biofilm.
Patent AU-2020381534-A1 (AU)
Title: Compositions and methods for activation of integrins
Inventor: ANDRE PATRICK
IPC: A61P21/00
Filed: 2020-11-13
Abstract: Disclosed herein are pharmaceutical agents and compositions that activate integrin heterodimers that contain beta-1 integrin protein that specifically bind laminin protein. Such agents and compositions are useful for treating diseases related to muscle malfunction, including muscular dystrophies.
Patent AU-2020397448-A1 (AU)
Title: Benzothia(di)azepine compounds and their use as bile acid modulators
Inventor: GILLBERG PER-GÖRAN
IPC: A61K31/554
Filed: 2020-12-04
Abstract: The invention relates to 1,5-benzothiazepine and 1,2,5-benzothiadiazepine derivatives of formula (I). These compounds are bile acid modulators having apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transport (LBAT) inhibitory activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases.
Patent AU-2020398163-A1 (AU)
Title: Tissue traction devices, systems, and methods
Inventor: LEE DANNY
IPC: A61B17/10
Filed: 2020-12-01
Abstract: The present disclosure relates generally to the field of medical devices. In particular, the present disclosure relates to a tissue traction device, e.g., for endoscopic tissue dissection. For example, a tissue traction device may include a first clip comprising opposable jaws. The device may include a traction band having a first end, a second end, a length therebetween and extending along a longitudinal axis. The band may have a first aperture at the first end. A second aperture may be at the second end of the band. A first jaw of the opposable jaws of the first clip may be disposed through the first aperture.
Patent AU-2020439973-A1 (AU)
Title: Liquid/fluid cooling systems for high power-density (HPD) transformers
Inventor: ZHOU ZHI
IPC: H01F27/12
Filed: 2020-03-31
Abstract: A high power-density power converter (500) employs a liquid cooling system (200) to cool its transformers (120). In an embodiment, the coils (135) of a transformer (100) are embedded in a heat-conducting solid (epoxy or resin). The resin-embedded coils (135) are in physical/thermal contact with cold plates (160), which are sandwiched between the coils (135) and/or in contact with exterior surfaces of the coils (135). The cold plates (160) may additionally or alternatively be in physical/thermal contact with the transformer core (145). Coolant fluid is pumped through the cold plates (160). In another embodiment, the transformer is (120) is immersed in a coolant fluid (740), such as oil, within a heat management enclosure (710). Cold plates (160) are in physical/thermal contact with the enclosure (710). Coolant liquid (240) pumped through the cold plates (160) conducts heat away from the oil-enclosed transformer (700).
Patent AU-2020465836-A1 (AU)
Title: Therapeutic antibody and uses thereof
Inventor: MENG XUN
IPC: G01N33/53
Filed: 2020-08-28
Abstract: Provided antibodies or antigen-binding fragment thereof specific for the variant exon v9 of the CD44 gene (CD44v9), antibody-drug-conjugate (ADC), and other derivative comprising the antibodies or antigen-binding fragment. Provided nucleic acid molecules encoding the same, and methods of making the same. Further provided pharmaceutical compositions comprising the same, and the use of the same in treating diseases or in the manufacture of a medicament for the treatment of the diseases, such as cancer.
Patent WO-2022047537-A1 (WO)
Title: Improvements in gamma-activation analysis measurements
Inventor: TICKNER JAMES
IPC: G01N23/2208
Filed: 2021-09-02
Abstract: A method and system are disclosed to determine a concentration of one or more target elements in a sample, using gamma activation analysis comprising: simultaneously irradiating the sample and a reference material containing at least two reference elements X-rays, detecting deactivation gamma-rays from the irradiated sample and the irradiated reference material; determining the concentration of the or each target element in the sample by correcting the number of detected deactivation gamma-rays from any of the or each target element present in the irradiated sample based on the number of detected deactivation gamma-rays from the at least two reference elements, wherein the at least two reference elements have a variation in activation rate over a pre-defined X-ray end-point energy range which differs from one another.
Patent WO-2022061402-A1 (WO)
Inventor: MEYER BERND
IPC: G01R22/10
Filed: 2021-09-22
Abstract: Embodiments generally relate to a method for allowing power supplied through a cable to be determined. The method comprises receiving magnetic field data, the magnetic field data relating to a magnetic field generated by the cable, receiving reference data, the reference data relating to a current supplied to one or more monitored loads powered through the cable; based on the received magnetic field data and reference data, determining at least one parameter of a function that relates the magnetic field generated by the cable to the power supplied through a cable; and making available the at least one parameter, so that a power supplied by the cable can be determined based on the at least one parameter and a magnetic field value. The one or more monitored loads are a subset of all the loads powered through the cable.
Patent AU-2021202394-A1 (AU)
Title: Bispecific EGFR/c-Met antibodies
Inventor: CHIU MARK
IPC: A61K33/243
Filed: 2021-04-20
Abstract: Figure IA.  
SEQ ID 
NO: 
18 LPAPKNLVVSEVTEDSLRLSWNDP-HGFYDSFLIQYQESEKVGEAINLTVPGSERSYDLTG (60) 
19 LPAPKNLVVSEVTEDSLRLSWrYD-RDGY SFLIQYQESEKVGEAINLTVPGSERSYDLTG 
20 LPAPKNLVVSEVTEDSLRLSW3YN-GDHE SFLIQYQESEKVGEAINLTVPGSERSYDLTG 
21 LPAPKNLVVSEVTEDSLRLSW DP-RGFY GSFLIQYQESEKVGFAINLTVPGSERSYDLTG 
22 LPAPKNLVVSEVTEDSLRLSWrWP-YADL'SFLIQYQESEKVGRAINLTVPGSERSYDLTG 
23 LPAPKNLVVSEVTEDSLRLSW YN-GDHF2SFLIQYQESEKVGEAINLTVPGSERSYDLTG 
24 LPAPKNLVVSEVTEDSLRLSW YDLGDHF SFLIQYQESEKVGEAINLTVPGSERSYDLTG 
25 LPAPKNLVVSEVTEDSLRLSW DP-WAFY CSFLIQYQESEKVGEAINLTVPGSERSYDLTG 
27 LPAPKNLVVSEVTEDSARLSW DP-WAFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 
29 LPAPKNLVVSEVTEDSLRLSW WP-YADL SFLIQYQESEKVGEAINLTVPGSERSYDLTG 
107 LPAPKNLVVSEVTEDSARLSW DP-HGFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 
108 LPAPKNLVVSEVTEDSARLSW DP-WAFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 
109 LPAPKNLVVSEVTEDSARLSW DP-HAF SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 
110 LPAPKNLVVSEVTEDSARLSWEDP-HGFY SFLIQYQESEKVGEAIVLTVPGSERSYDLTG 
18 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAEFTT (94) 
19 LKPGTEYTVSIYGV INVYKDTNMRG PLSAEFTT 
20 LKPGTEYTVSIYGVINVYKDTNMRGIPLSAEFTT 
21 LKPGTEYTVSIYGViNVYKDTNMRGIPLSAEFTT 
22 LKPGTEYTVSIYGViNVYKDTNMRGIPLSAEFTT 
23 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAEFTT 
24 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAEFTT 
25 LKPGTEYTVSIYGV JNVYKDTNMRGI PLSAEFTT 
27 LKPGTEYTVSIYGV NVYKDTNMRGI PLSAIFTT 
29 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAEFTT 
107 LKPGTEYTVSIYGV INVYKDTNMRGI PLSAIFTT 
108 LKPGTEYTVSIYGV INVYKDTNIRGI PLSAIFTT 
109 LKPGTEYTVSIYGV INVYKDTNIRGI PLSAIFTT 
110 LKPGTEYTVSIYGV NVYKDTIRGI PLSAIFTT 
Bispecific EGFR/c-Met antibodies and methods making and using the molecules.  
Epidermal growth factor receptor (EGFR, ErbBI or HERI) is a Type I transmembmne 
glycoprotein of 170 kDa thai is encoded by the c-erbBI proto-oncogene. EGFR is a 
member of the human epidermal growth factor receptor (HER) family of receptor tyrosine 
kinases (RTK) which includes HER2 (ErbB2), HER3 (ErbB3) and HER4 (ErbB4). EGFR 
signaling is initiated by ligand binding followed by induction of conformational change, 
homodimerizalion or heteromdimerization of the receptor with other ErbB family 
members.
Patent AU-2021204574-A1 (AU)
Title: Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome
Inventor: BERRY DAVID
IPC: A61K35/39
Filed: 2021-06-30
Abstract: Probiotic compositions containing non-pathogenic microbial entities, e.g., bacterial 
entities, are described herein. The probiotic compositions may optionally contain or be used 
in conjunction with one or more prebiotics. Uses of the probiotic compositions to treat or 
prevent disorders of the local or systemic microbiome in a subject are also provided.  
513 
ME1 21550197v.1
Patent AU-2021205910-A1 (AU)
Title: Use of amino acids to enhance signal in mass spectral analyses
Inventor: MAO YUAN
IPC: G01N33/68
Filed: 2021-01-07
Abstract: A method of enhancing a mass spectral signal is disclosed. The method can include contacting a sample to a separation column under conditions that permit sample components to bind to the substrate; applying a first mobile gradient to the separation column, wherein the first mobile phase gradient comprises trifluoroacetic acid (TFA) and a small molecule additive (
Patent AU-2021206853-A1 (AU)
Title: Ankle replacement system and method
Inventor: STEMNISKI PAUL
IPC: A61B17/90
Filed: 2021-07-21
Abstract: Various surgical devices and methods are disclosed herein. Also disclosed is multi 
component prosthesis. One of the disclosed surgical alignment systems includes a guide arm, 
a ratchet arm frame configured to be coupled slidably to the guide arm, a ratchet arm 
configured to be coupled to the ratchet arm frame, and a sagittal sizing guide body configured 
to be coupled to the ratchet arm. The sagittal sizing guide body includes a first radiopaque 
object disposed at a first position and a second radiopaque object disposed at a second 
position that is spaced apart from the first position
Patent AU-2021219060-A1 (AU)
Title: Massage bar
Inventor: GRECO JOSEPH
IPC: A61K8/02
Filed: 2021-02-11
Abstract: A personal care cosmetic composition; its method of manufacture; and its method of use are disclosed.
Patent AU-2021268653-A1 (AU)
Title: Remineralizing oral care compositions comprising tin
Inventor: BAIG ARIF ALI
IPC: A61K8/25
Filed: 2021-05-05
Abstract: Dentifrice compositions including tin, monodentate ligand, polydentate ligand with low RDA values. Dentifrice compositions with a unique ratio of monodentate ligand to polydentate ligand to stabilize tin. Oral care compositions including tin with unexpectedly low stain at lower RDA values. Dentifrice compositions including tin and silica with an unexpectedly low stain and RDA value.
Patent AU-2021290404-A1 (AU)
Title: Audio signal processing device, audio signal processing method, and audio signal processing program
Inventor: TSUTSUMI KIMITAKA
IPC: G10L19/00
Filed: 2021-12-29
Abstract: AUDIO SIGNAL PROCESSING DEVICE, AUDIO SIGNAL PROCESSING METHOD, 
AND AUDIO SIGNAL PROCESSING PROGRAM 
ABSTRACT 
An audio signal processing method to be executed by an audio signal processing device. The 
audio signal processing method comprises determining an occurrence of a discontinuity of 
decoded audio, the discontinuity occurring with a sudden increase of an amplitude of the 
decoded audio, the decoded audio being obtained by decoding a first audio packet which is 
received correctly after an occurrence of a packet loss; and correcting the discontinuity of the 
decoded audio. The step of correcting equally spaces ISF/LSF parameters corresponding to a 
frame in which the packet loss has occurred.
Patent AU-2021292484-A1 (AU)
Title: ALK2 inhibitors for the treatment of anemia
Inventor: SÉGUY FRANCIS
IPC: A61K31/4439
Filed: 2021-06-15
Abstract: Provided herein are methods of treating anemia in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an ALK2 inhibitor.
Patent AU-2021321050-A1 (AU)
Title: Starch-containing solid composition and method for producing same
Inventor: HIBI Naruhiro
IPC: A23L5/00
Filed: 2021-08-06
Abstract: Provided is a starch-containing solid composition having both preferable elasticity during water retention and low viscosity during water retention when heated under water-containing conditions. The composition satisfies all of (1) to (4) below. (1) The starch content in the composition is 20 mass% or more in terms of dry mass. (2) (a) and/or (b) below are satisfied.　(a) 300 pieces/mm
Patent AU-2021327743-A1 (AU)
Title: Portable vessel, regulator and apparatus for storing fluids
Inventor: JENKINS JARVIS
IPC: B65D83/38
Filed: 2021-08-20
Abstract: Portable vessels, regulators, apparatus, and methods for storing fluids under pressure are disclosed.
Patent AU-2021328481-A1 (AU)
Title: Wearable auscultation device
Inventor: MOEHRING MARK A
IPC: A61B7/04
Filed: 2021-08-19
Abstract: Provided herein are systems, devices, and methods to measure auditory signals from a subject to determine a state of a subject. The auditory signals measured may provide a tool to monitor the development of disease state(s) or abnormal physiologic conditions (e.g., wheezing, fluid accumulation, abnormal heart murmur or rhythm, etc).
Patent AU-2021365165-A1 (AU)
Title: Fluid container management system
Inventor: BUSE DAVID A
IPC: B65G47/84
Filed: 2021-10-21
Abstract: Systems and methods for transferring containers (100) include or employ a container loading interface (200), a container storage module (400), and a container distributor (300) configured to transfer containers from the container loading interface to the container storage module. The container loading interface includes movable support platform (202) that is movable between accessible and a non-accessible positions and a container loading transport (214). The container storage module includes a housing (402) and a container storage transport (418). The container distributor includes a container gripper (320) configured to grasp a container on the container loading transport and to transfer the container to the container storage transport in the container storage module.
Patent AU-2021402243-A1 (AU)
Title: System and method for enhancing visualization of an eye image
Inventor: YIN LU
IPC: H04N1/62
Filed: 2021-10-21
Abstract: A system and method for visually enhancing an original image of an eye includes a visualization module. A controller is configured to convert an output of the visualization module to a first pixel cloud in a first color space and map the first pixel cloud to a second pixel cloud in a second color space. The method includes identifying at least one selected zone in the second color space. The controller is configured to move the selected zone from an original location to a modified location in the second color space. The second pixel cloud is updated to obtain a modified second pixel cloud, which is transformed into a third pixel cloud in the first color space. An enhanced image is formed based in part on the modified second pixel cloud and provides selective visual enhancement in the selected zone without affecting contrast in a remainder of the original image.
Patent AU-2021408146-A1 (AU)
Title: Equipment and method for recovering flexible pipes without the use of special vessels
Inventor: FIORENZA DE LIMA HENRI
IPC: B63B35/03
Filed: 2021-11-25
Abstract: The present invention relates to equipment for recovering flexible pipes without the use of special vessels, using less costly resources and without the obligation not to damage said apparatus during the handling thereof, as it applies to pipes at the end of their service life or that are already damaged. These types of pipes are a significant liability for some operators in the oil industry. The technology, for use in field demobilization phases or even for recovering pipes without any prospect of use, uses vessels with minimal adaptations including the presence of recovery/laying wheels with a much smaller diameter compared to the wheels used on conventional vessels or, alternatively, the launching of a special recovery reel with its own drive means in order to allow the winding of the abandoned pipes at the launch site, with subsequent recovery of the assembly and transfer to the vessel itself.
Patent AU-2021409515-A1 (AU)
Title: Novel quinazoline derivatives as SOS1 inhibitors and use thereof
Inventor: CHOI JAE YUL
IPC: C07D239/94
Filed: 2021-12-14
Abstract: The present invention relates to a novel quinazoline derivative compound that serves as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel quinazoline derivative compound having inhibitory activity against SOS1 binding to RAS family proteins and/or RAC1; a pharmacologically acceptable salt thereof; or a pharmaceutical composition containing the compound.
Patent AU-2021412269-A1 (AU)
Title: Mower
Inventor: JI QIN
IPC: A01D75/00
Filed: 2021-12-27
Abstract: A mower (100) includes a body (10), a working unit (30), a wheel unit (60), a platform (41) and a pedal (42). The working unit (30) is coupled to the body (10). The wheel unit (30) is mounted on the body (10) and includes a front wheel unit (61) and a rear wheel unit (62). The platform (41) is mounted on the body (10) and is located on a side of the rear wheel unit (62) away from the front wheel unit (61). The pedal (42) is in an axial direction of the rear wheel unit (62) and located on a side of the body (10). A height of the pedal (42) to ground is greater than a height of the platform (41) to the ground. When the mower (100) is on a slope, users may stand steadily, stand upright, and may easily adjust their own center of gravity, so that the mower (100) is not easy to be overturned.